Cite
HARVARD Citation
Chabre, O. et al. (2022). Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence. Lancet. 10 (6), pp. 384-385. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chabre, O. et al. (2022). Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence. Lancet. 10 (6), pp. 384-385. [Online].